Occult primary Journal Article


Authors: Ettinger, D. S.; Agulnik, M.; Cates, J. M. M.; Cristea, M.; Denlinger, C. S.; Eaton, K. D.; Fidias, P. M.; Gierada, D.; Gockerman, J. P.; Handorf, C. R.; Iyer, R.; Lenzi, R.; Phay, J.; Rashid, A.; Saltz, L.; Shulman, L. N.; Smerage, J. B.; Varadhachary, G. R.; Zager, J. S.; Zhen, W.
Article Title: Occult primary
Keywords: cancer survival; leukemia; cancer surgery; unclassified drug; review; squamous cell carcinoma; cisplatin; fluorouracil; cancer combination chemotherapy; united states; gemcitabine; paclitaxel; cancer radiotherapy; chemotherapy; methodology; lymph node metastasis; antineoplastic agent; endometrioid carcinoma; lymph node dissection; lymphatic metastasis; organization and management; colorectal cancer; adenocarcinoma; prostate specific antigen; carboplatin; melanoma; metastasis; multiple cycle treatment; ovary cancer; breast cancer; etoposide; antineoplastic combined chemotherapy protocols; protein; nccn clinical practice guidelines; practice guideline; continuous infusion; pathology; oncology; algorithms; cancer mortality; docetaxel; legal aspect; lung small cell cancer; lung adenocarcinoma; societies, medical; algorithm; uterine cervix cancer; lymphoma; practice guidelines as topic; carcinoma; medical society; mesothelioma; medical oncology; pancreas adenocarcinoma; protein s 100; melan a; bile duct carcinoma; thyroid cancer; prostate adenocarcinoma; cancer of unknown primary site; antibodies; wt1 protein; estrogen receptor; progesterone receptor; thyroglobulin; stomach adenocarcinoma; life expectancy; antibody; cd45 antigen; non seminomatous germinoma; uterine cervix carcinoma; calretinin; mesothelin; monoclonal antibody d2-40; metastatic; transcription factor cdx2; epithelial membrane antigen; thyroid transcription factor 1; neoplasms, unknown primary; nccn guidelines; molecular diagnosis; molecular diagnostic techniques; occult primary; uroplakin; mammaglobin; carcinoma of unknown primary; placenta like alkaline phosphatase; villin
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 9
Issue: 12
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2011-12-01
Start Page: 1358
End Page: 1395
Language: English
PUBMED: 22157556
PROVIDER: scopus
DOI/URL:
Notes: --- - "Export Date: 7 May 2013" - ": Chemicals/CAScarboplatin, 41575-94-4; cisplatin, 15663-27-1, 26035-31-4, 96081-74-2; docetaxel, 114977-28-5; etoposide, 33419-42-0; fluorouracil, 51-21-8; gemcitabine, 103882-84-4; paclitaxel, 33069-62-4; protein, 67254-75-5; thyroglobulin, 9010-34-8; villin, 120433-11-6; Antibodies" - "Source: Scopus"
Citation Impact
MSK Authors
  1. Leonard B Saltz
    791 Saltz